ArticleOxford medical case reports2022

Long-term response to olaparib in a patient with metastatic pancreatic cancer associated with hereditary breast and ovarian cancer syndrome.

Michiko Tsuneizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.